Our friend on Twitter is giving us a plug; thanks Yan Leyfman
In a trial of 222 mechanically ventilated #COVID19 patients with mod/severe #ARDS, #MSC therapy reduced #mortality by 48% at 90 days with improved respiratory function by Day 7. When combined with #dexamethasone, 90-day mortality was reduced by 77%.
Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT, page-32
-
- There are more pages in this discussion • 220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
89.5¢ |
Change
-0.020(2.19%) |
Mkt cap ! $1.021B | |||
| Open | High | Low | Value | Volume |
| 90.5¢ | 90.5¢ | 89.5¢ | $1.379M | 1.536M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 187597 | 89.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.0¢ | 136792 | 33 |
View Market Depth
| Last trade - 10.56am 08/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |